Susanna Dienemann, LL.M.

Rechtsanwältin, Partner
Phone / Email
+49 451 31 70 260 - 0
s.dienemann@wachenhausen-law.com
Downloads
CV       V-Card


Make appointment

Write an email
Make appointment
Visit LinkedIn Profile
Susanna Dienemann, LL.M.

Susanna Dienemann has been a partner since 2015 and became a name partner of Wachenhausen Dienemann Rechtsanwälte since 2023. She has been working successfully with founding partner Prof. Dr. Heike Wachenhausen since 2012. Ms Dienemann focuses her practice on matters relating to clinical research, in particular, questions concerning contractual arrangements. She also advises clients on regulatory matters both concerning medicinal products and medical devices. In addition, she assists clients in advertising medicinal products and medical devices and anti-corruption compliance in the healthcare sector.

Ms Dienemann gained significant in-house experience during two secondments to the legal department of the Pharmaceuticals Division of Bayer AG (former: Bayer Pharma AG). Prior to joining Wachenhausen Dienemann Rechtsanwälte she worked for the pharmaceuticals, medical devices and foods practice group at Arnold & Porter Kaye Scholer LLP’s (former: Arnold & Porter (UK) LLP) London office.

Ms Dienemann studied at the Ludwig Maximilian University of Munich and at Trinity College Dublin.

She regularly publishes articles on issues relating to pharmaceutical and medical devices law and is an experienced speaker at professional events and in-house trainings. Additionally, Ms Dienemann is a member of the “Legal Affairs” and “Admissions” committees of the German Pharmaceutical Industry Association (BPI).

Moreover, she has been a lecturer in the programme “Master of Pharma Business Administration” at the Goethe University Frankfurt/Main since 2017 and has been an honorary member of the Ethics Committee of the University of Lübeck since 2022.

Ms Dienemann provides legal advice in German and in English.


Memberships

Bundesverband der Pharmazeutischen Industrie e.V. (BPI)
Kanzleimitgliedschaft Wachenhausen Dienemann Rechtsanwälte

Persönliches Mitglied des Ausschusses Recht des BPI

Persönliches Mitglied des Ausschusses Zulassung des BPI

Persönliches Mitglied bei der Deutschen Gesellschaft für Pharmazeutische Medizin (DGPharMed)

INTEGRITAS Verein für lautere Heilmittelwerbung e.V.
Kanzleimitgliedschaft Wachenhausen Dienemann Rechtsanwälte

Life Science Nord e.V.
Kanzleimitgliedschaft Wachenhausen Dienemann Rechtsanwälte

Förderkreis der Forschungsstelle für Pharmarecht an der Philipps-Universität Marburg e.V.
Kanzleimitgliedschaft Wachenhausen Dienemann Rechtsanwälte

Lectures

Haftung PRRC beim Hersteller

Susanna Dienemann, LL.M.

Online-Seminar
05. November 2024
qtec group

Das neue Medizinforschungsgesetz

Susanna Dienemann, LL.M.

München
22. November 2024
Arbeitsgruppe Life Sciences der Licensing Executives Society (LES)

Medizinforschungsgesetz

Susanna Dienemann, LL.M.

Frankfurt
14. Oktober 2024
BPI, Rechtsausschuss

Publications

Das neue Medizinforschungsgesetz

Susanna Dienemann, LL.M.
A&R 2024, S.182

Das PMCF – Verpflichtungen nach der neuen EU-Medizinprodukteverordnung

Susanna Dienemann, LL.M.
PM QM 1/2019, S. 52 ff.

Das 4. AMG-Änderungsgesetz – Wo stehen wir derzeit?

Susanna Dienemann, LL.M.
Pharmazeutische Medizin 2017, S. 82 ff